For patients with low back pain caused by a herniated disk, expectations of good results without surgery are the main factor affecting the preference for nonsurgical treatment, reports a study in the November 15 issue of Spine.
Expectations drive patient preferences for treatment of spine problems
Published in November 17th, 2008
Comments Off
New and improved scientific method to forecast the demand for key anti-malarial treatments
Published in November 17th, 2008
Comments Off
Treating infectious diseases while meeting escalating costs to do so continues to pose worldwide challenges, with one of the main issues being the ability to provide an adequate supply of drugs to treat infectious diseases.
Mayo Clinic Develops Potential New Therapy to Stop the Progression of Parkinson’s Disease
Published in November 17th, 2008
Comments Off
Mayo Clinic ( http://www.mayoclinic.org/ ) researchers have developed a method to reduce the production of alpha-synuclein in the brain.
‘Invasiveness Index’ Helps in Assessing Risks of Spinal Surgery
Published in November 17th, 2008
Comments Off
A new “invasiveness index” is closely related to key measures of the magnitude of spinal surgery, reports a study in the November 15 issue of Spine.
Expectations Drive Patient Preferences for Treatment of Spine Problems
Published in November 17th, 2008
Comments Off
For patients with low back pain caused by a herniated disk, expectations of good results without surgery are the main factor affecting the preference for nonsurgical treatment, reports a study in the November 15 issue of Spine.
Applying ’supply and demand’ business principles to treat infectious diseases worldwide
Published in November 17th, 2008
Comments Off
Treating infectious diseases while meeting escalating costs to do so continues to pose worldwide challenges, with one of the main issues being the ability to provide an adequate supply of drugs to treat infectious diseases.
Innocoll receives fast track designation for Gentamicin surgical implant
Published in November 17th, 2008
Comments Off
Innocoll, Inc., a privately-held biopharmaceutical company, announced that the FDA has designated Gentamicin surgical implant as a Fast Track development program.
Healthiest U.S. City: Lincoln, Nebraska
Published in November 17th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
Huntington, W.V. is deemed the least healthy U.S. city, according to a report by the CDC.
WebMD Health News
Rifampin May Be Better Tolerated Than Isoniazid for Latent Tuberculosis
Published in November 17th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
A randomized trial showed that treatment of latent tuberculosis with 4 months of rifampin was associated with fewer serious adverse events and better adherence than 9 months of isoniazid.
Medscape Medical News
ASHG 2008: Genomewide Association Study Finds Genetic Predictors of Warfarin Required Dose
Published in November 17th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
Genetic information enables researchers to predict 50% or more of individual variation in required warfarin dosage.
Medscape Medical News